日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Long-term outcomes in FLT3-mutated acute myeloid leukemia after frontline hypomethylating agent, venetoclax and a FLT3 inhibitor

一线去甲基化药物维奈托克联合FLT3抑制剂治疗FLT3突变型急性髓系白血病患者的长期疗效

Short, Nicholas J; Loghavi, Sanam; Yilmaz, Musa; Karrar, Omer; Kim, Kunhwa; Dinardo, Courtney D; Kadia, Tapan M; Maroun, Manuel; Borthakur, Gautam; Issa, Ghayas C; Jabbour, Joseph; Oran, Betul; Shpall, Elizabeth J; Popat, Uday; Patel, Keyur P; Routbort, Mark; Konopleva, Marina; Ravandi, Farhad; Kantarjian, Hagop; Daver, Naval

Outcomes of Frontline Triplet Regimens With a Hypomethylating Agent, Venetoclax, and Isocitrate Dehydrogenase Inhibitor for Intensive Chemotherapy-Ineligible Patients With Isocitrate Dehydrogenase-Mutated AML

对于不适合接受强化化疗的异柠檬酸脱氢酶突变型急性髓系白血病患者,一线三联疗法(包括去甲基化药物、维奈托克和异柠檬酸脱氢酶抑制剂)的疗效

DiNardo, Courtney D; Marvin-Peek, Jennifer; Loghavi, Sanam; Takahashi, Koichi; Issa, Ghayas C; Jen, Wei-Ying; Daver, Naval G; Reville, Patrick K; Short, Nicholas J; Sasaki, Koji; Mullin, Jillian K; Bradley, Corey A; Borthakur, Gautam; Maiti, Abhishek; Alvarado, Yesid; Pemmaraju, Naveen; Abbas, Hussein A; Hammond, Danielle E; Haddad, Fadi; Bravo, Guillermo Montalban; Chien, Kelly S; Yilmaz, Musa; Kornblau, Steven M; Jabbour, Elias; Ravandi, Farhad; Kadia, Tapan; Garcia-Manero, Guillermo; Konopleva, Marina Y; Kantarjian, Hagop M

A phase 1/2 study of DS-1594 menin inhibitor in relapsed/refractory acute leukemias

DS-1594 menin抑制剂治疗复发/难治性急性白血病的1/2期研究

Senapati, Jayastu; Konopleva, Marina; Issa, Ghayas C; Jabbour, Elias; Kadia, Tapan; DiNardo, Courtney; Borthakur, Gautam; Pemmaraju, Naveen; Short, Nicholas J; Yilmaz, Musa; Deshmukh, Indraneel; Alvarez, Joie; Loghavi, Sanam; Tang, Guilin; Abbas, Hussein A; Andreeff, Michael; Bhalla, Kapil; Midde, Narasimha M; Said, Nabil; Noyalis, Amy; Mires, Derek E; Ning, Jing; Xiao, Lianchun; Ravandi, Farhad; Garcia-Manero, Guillermo; Kantarjian, Hagop M; Daver, Naval G

Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia

维奈托克联合FLAG-IDA方案诱导和巩固治疗新诊断、复发或难治性急性髓系白血病的长期疗效

DiNardo, Courtney D; Jen, Wei-Ying; Takahashi, Koichi; Kadia, Tapan M; Loghavi, Sanam; Daver, Naval G; Xiao, Lianchun; Reville, Patrick K; Issa, Ghayas C; Short, Nicholas J; Sasaki, Koji; Wang, Sa A; Mullin, Jillian K; Pierce, Sherry; Bradley, Corey; Borthakur, Gautam; Maiti, Abhishek; Alvarado, Yesid; Pemmaraju, Naveen; Ferrajoli, Alessandra; Swaminathan, Mahesh; Ohanian, Maro; Abbas, Hussein A; Hammond, Danielle; Burger, Jan; Haddad, Fadi; Montalban-Bravo, Guillermo; Chien, Kelly; Masarova, Lucia; Yilmaz, Musa; Jain, Nitin; Andreeff, Michael; Garcia-Manero, Guillermo; Kornblau, Steven; Ravandi, Farhad; Jabbour, Elias; Konopleva, Marina Y; Kantarjian, Hagop M

Outcomes of adult patients with newly diagnosed IDH-mutated AML treated with intensive chemotherapy and venetoclax

接受强化化疗和维奈托克治疗的初诊IDH突变型AML成年患者的预后

Croden, Jennifer; Jen, Wei-Ying; Marvin-Peek, Jennifer; Xiao, Lianchun; Bouligny, Ian M; Loghavi, Sanam; Borthakur, Gautam; Daver, Naval G; Abbas, Hussein A; Takahashi, Koichi; Sasaki, Koji; Pemmaraju, Naveen; Short, Nicholas J; Hammond, Danielle; Jabbour, Elias; Masarova, Lucia; Chien, Kelly S; Issa, Ghayas C; Montalban-Bravo, Guillermo; Yilmaz, Musa; Maiti, Abhishek; Alvarado-Valero, Yesid; Garcia-Manero, Guillermo; Ravandi, Farhad; Konopleva, Marina Y; Kantarjian, Hagop M; Kadia, Tapan M; DiNardo, Courtney D

Optimizing lower intensity triplet therapy in acute myeloid leukemia: a practical guide

优化急性髓系白血病低强度三联疗法:实用指南

Jen, Wei-Ying; Lachowiez, Curtis A; Marvin-Peek, Jennifer; Altman, Jessica K; Yilmaz, Musa; Garcia, Jacqueline S; Abaza, Yasmin; Short, Nicholas J; Zeidner, Joshua F; Daver, Naval G; Wei, Andrew H; Issa, Ghayas C; DiNardo, Courtney D

Azacitidine, Venetoclax, and Magrolimab in Newly Diagnosed and Relapsed Refractory Acute Myeloid Leukemia: Phase Ib/II Study and Correlative Analysis

阿扎胞苷、维奈托克和马格罗利单抗治疗新诊断和复发难治性急性髓系白血病:Ib/II期研究及相关性分析

Daver, Naval; Senapati, Jayastu; Kantarjian, Hagop M; Wang, Bofei; Reville, Patrick K; Loghavi, Sanam; Yilmaz, Musa; DiNardo, Courtney D; Kadia, Tapan M; Yassouf, Mhd Yousuf; Maiti, Abhishek; Arora, Sankalp; Montalban Bravo, Guillermo; Tang, Guilin; Borthakur, Gautam; Sasaki, Koji; Pemmaraju, Naveen; Alvarez, Joie; Nogueras Gonzalez, Graciela M; Ning, Jing; Issa, Ghayas C; Konopleva, Marina; Andreeff, Michael; Ravandi, Farhad; Garcia-Manero, Guillermo; Abbas, Hussein A

Hyper-CVAD and Sequential Blinatumomab Without and With Inotuzumab in Young Adults With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia

在初诊为费城染色体阴性B细胞急性淋巴细胞白血病的年轻成人患者中,采用Hyper-CVAD方案和序贯Blinatumomab方案(不联合或联合Inotuzumab)治疗。

Kantarjian, Hagop; Short, Nicholas J; Jain, Nitin; Haddad, Fadi G; Kadia, Tapan; Yilmaz, Musa; Ferrajoli, Alessandra; Sasaki, Koji; Alvarado, Yesid; Pemmaraju, Naveen; Senapati, Jayastu; Garris, Rebecca; Ravandi, Farhad; Jabbour, Elias

Clinical interrogation of TP53 aberrations and its impact on survival in patients with myeloid neoplasms

TP53 异常的临床研究及其对髓系肿瘤患者生存的影响

Senapati, Jayastu; Loghavi, Sanam; Garcia-Manero, Guillermo; Tang, Guillin; Kadia, Tapan; Short, Nicholas J; Abbas, Hussein A; Arani, Naszrin; DiNardo, Courtney D; Borthakur, Gautam; Pemmaraju, Naveen; Oran, Betul; Shpall, Elizabeth; Popat, Uday; Champlin, Richard; Pierce, Sherry; Arora, Sankalp; Issa, Ghayas; Yilmaz, Musa; Patel, Keyur; Takahashi, Koichi; Montalban-Bravo, Guillermo; Hammond, Danielle; Haddad, Fadi G; Ravandi, Farhad; Kantarjian, Hagop M; Daver, Naval G

A pharmacokinetic and safety study of oral arsenic trioxide in patients with acute promyelocytic leukemia

一项关于口服三氧化二砷治疗急性早幼粒细胞白血病患者的药代动力学和安全性研究

Ravandi, Farhad; Rangaraju, Sravanti; Kantarjian, Hagop; Garcia-Manero, Guillermo; Yilmaz, Musa; Baker, Kristen; Hall, Terence; Grabenstein, Joy; Roy, Pourab; Zamboni, Beth A; Zamboni, William C; Warlick, Erica; Kelly, Michael; Roth, David A; Ghiaur, Gabriel